| scholarly article | Q13442814 |
| P2093 | author name string | Shira R Goldenholz | |
| Daniel M Goldenholz | |||
| P2860 | cites work | Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy | Q21563404 |
| Surgery for epilepsy | Q24186613 | ||
| Analgesic effects of branding in treatment of headaches | Q24551033 | ||
| Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304 | Q24621743 | ||
| Placebo effects: from the neurobiological paradigm to translational implications | Q26996428 | ||
| Delayed effect of craniotomy on experimental seizures in rats | Q27301277 | ||
| Early identification of refractory epilepsy | Q28144133 | ||
| Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials | Q28248717 | ||
| Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy | Q30537624 | ||
| Confusing placebo effect with natural history in epilepsy: A big data approach | Q30978984 | ||
| Magnitude of the placebo effect in randomized trials of antiepileptic agents | Q31133698 | ||
| New antiepileptic drugs: comparison of key clinical trials. | Q33674144 | ||
| Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment | Q33948133 | ||
| The powerful placebo | Q33969075 | ||
| Placebo effect in canine epilepsy trials | Q34020168 | ||
| Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy | Q34021795 | ||
| Placebo response in studies of major depression: variable, substantial, and growing | Q34122652 | ||
| Rates and predictors of long-term seizure freedom after frontal lobe epilepsy surgery: a systematic review and meta-analysis | Q34150430 | ||
| Surgery as placebo. A quantitative study of bias | Q34247380 | ||
| The powerful placebo effect: fact or fiction? | Q34454577 | ||
| A systematic review of placebo response in studies of bipolar mania | Q34686878 | ||
| An estimate of placebo effect of repetitive transcranial magnetic stimulation in epilepsy | Q34688971 | ||
| The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design Approach | Q35111772 | ||
| Placebo effect of medication cost in Parkinson disease: a randomized double-blind study | Q35134917 | ||
| Remission and relapse in a drug-resistant epilepsy population followed prospectively | Q35138587 | ||
| Randomized controlled trials of epilepsy surgery | Q35200136 | ||
| Time to prerandomization monthly seizure count in perampanel trials: A novel epilepsy endpoint | Q35639962 | ||
| Patterns of treatment response in newly diagnosed epilepsy. | Q35948540 | ||
| Seizure remission in adults with long-standing intractable epilepsy: an extended follow-up | Q37147732 | ||
| Long-term seizure outcome of surgery versus no surgery for drug-resistant partial epilepsy: a review of controlled studies | Q37401389 | ||
| Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis | Q37594857 | ||
| Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects | Q37671448 | ||
| Altered placebo and drug labeling changes the outcome of episodic migraine attacks | Q37734237 | ||
| Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis | Q37832531 | ||
| What clinical trial designs have been used to test antiepileptic drugs and do we need to change them? | Q38043471 | ||
| Characterization of the thalamic-subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients | Q38181287 | ||
| Adverse events of placebo-treated, drug-resistant, focal epileptic patients in randomized controlled trials: a systematic review. | Q38219326 | ||
| Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010. | Q39375980 | ||
| A two-way enriched clinical trial design: combining advantages of placebo lead-in and randomized withdrawal | Q44216589 | ||
| Likelihood of seizure remission in an adult population with refractory epilepsy | Q44530464 | ||
| Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial | Q44863362 | ||
| Clinical trials for therapeutic assessment of antiepileptic drugs in the 21st century: obstacles and solutions | Q45327908 | ||
| Seizure control resulting from intrahippocampal depth electrode insertion | Q48292934 | ||
| Responsive cortical stimulation for the treatment of medically intractable partial epilepsy | Q48591760 | ||
| Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs | Q50158883 | ||
| And Pavlov still rings a bell: summarising the evidence for the use of a bell in Pavlov's iconic experiments on classical conditioning. | Q50571716 | ||
| How "blind" are double-blind studies? | Q51161672 | ||
| Sudden unexpected death in epilepsy: assessing the public health burden. | Q51248582 | ||
| Placebo responses in randomized trials of antiepileptic drugs. | Q51774806 | ||
| Clinical features associated with placebo response in refractory focal epilepsy. | Q52884583 | ||
| Regression to the mean: treatment effect without the intervention. | Q53311733 | ||
| Powerful placebo: the dark side of the randomised controlled trial. | Q55067910 | ||
| Placebo Effects in Medicine | Q60304535 | ||
| Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study | Q61822712 | ||
| Heterogeneity of clinical response during placebo treatment | Q68182880 | ||
| A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group | Q72541815 | ||
| Results of treatment changes in patients with apparently drug-resistant chronic epilepsy | Q79661881 | ||
| The influence of a placebo, body position and medication on motion sickness | Q82132878 | ||
| When is a postoperative seizure equivalent to "epilepsy recurrence" after epilepsy surgery? | Q84043395 | ||
| Course and outcome of childhood epilepsy: a 15-year follow-up of the Dutch Study of Epilepsy in Childhood | Q84429267 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | placebo | Q269829 |
| P304 | page(s) | 15-25 | |
| P577 | publication date | 2016-02-10 | |
| P1433 | published in | Epilepsy Research | Q15746405 |
| P1476 | title | Response to placebo in clinical epilepsy trials--Old ideas and new insights | |
| P478 | volume | 122 |
| Q36332317 | A big data approach to the development of mixed-effects models for seizure count data. |
| Q64969184 | A double-blinded randomised dietary supplement crossover trial design to investigate the short-term influence of medium chain fatty acid (MCT) supplement on canine idiopathic epilepsy: study protocol. |
| Q47658584 | A multi-dataset time-reversal approach to clinical trial placebo response and the relationship to natural variability in epilepsy |
| Q41720453 | Cannabidiol and Epilepsy: Sifting, Winnowing and Buzz |
| Q50509778 | Does accounting for seizure frequency variability increase clinical trial power? |
| Q90719786 | Exploring generic brittleness and the demographic factors for its susceptibility in patients with epilepsy |
| Q28069705 | Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases |
| Q50104990 | Is seizure frequency variance a predictable quantity? |
| Q41357908 | Monte Carlo simulations of randomized clinical trials in epilepsy. |
| Q90329530 | Natural variability in seizure frequency: Implications for trials and placebo |
| Q53277220 | Not all that glitters is gold: A guide to the critical interpretation of drug trials in epilepsy. |
| Q92897551 | Schizophrenia Pharmacology: Past, Present, and Future Targets for Intervention |
| Q54936045 | Simulating Clinical Trials With and Without Intracranial EEG Data. |
| Q64885583 | Take Two Deep Breaths and Call Me in the Morning. |
Search more.